Pharmaceutical Sector

Venus Remedies gets GMP Certification from Kenya

Venus Remedies gets GMP Certification from Kenya Pharmaceutica

Suven gets first Certificate of Suitablity for API product ‘Tamsulosin HCL’

Suven gets first Certificate of Suitablity for API product ‘Tamsulosin HCL’

Piramal group launches project to fight chronic diseases

US Trade Body Clears Sun’s Purchase Of Taro

The Sun Pharma is all set to buy Israel-drug maker Taro. The US Federal Trade US Trade Body Clears Sun’s Purchase Of Taro Commission (FTC) has given its approval for the deal on certain conditions. The Mumbai-based drug maker Sun has to sell rights and assets of its anti-epilepsy drugs. Carbamazepine is a major anti-epilepsy brand prepared buy sun group. The Sun Pharma is ready to sell three distinct generic formulations to Torrent Pharmaceutical Ltd. Torrent Pharmaceutical Ltd is a major drug maker of Gujrat.

Panacea Biotec Secures Rs 143 Cr Order From UNICEF

‘Easy Five’, is a vaccine, which combats five infections diseases of early childhood.
Panacea Biotec Secures Rs 143 Cr Order From UNICEF
Biotechnology firm Panacea Biotec has secured Rs 143 crore-contract from the United Nations Children’s Fund (UNICEF) for supplying this vaccine.  

Panacea Biotec is the first Indian pharmaceutical company to get this order from UNICEF for its vaccines in fully liquid form, the company informed the Bombay Stock Exchange.  

The order starts in 2008 and would continue till 2009.

Cadila, WHO to jointly develop ‘Special Lifesaving Anti-Rabies Drug’

Cadila, WHO to jointly develop ‘Special Lifesaving Anti-Rabies Drug’Ahmedabad-based pharmaceutical major, Cadila Healthcare Ltd (Zydus Cadila), has entered into an agreement with the World Health Organisation (WHO) to explore a possible collaboration in the development of a drug for the treatment of rabies, through the use of monoclonal antibodies.

Pages